This report describes three patients who developed cytomegalovirus infection 4 months after high-risk donor+/recipient-(D+/R-) kidney transplantation, despite treatment with valgancyclovir (VGCV) for 3 months at low dose (450 mg/d).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.transproceed.2011.11.036 | DOI Listing |
Publication Analysis
Top Keywords
cytomegalovirus infection
8
infection prophylactic
4
prophylactic valganciclovir
4
valganciclovir therapy
4
therapy post-kidney
4
post-kidney transplantation
4
transplantation case
4
case reports
4
reports report
4
report describes
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!